SEC 13F Intelligence

Axel Capital Management, LLC / ABBV

Axel Capital Management, LLC’s Abbvie Inc Position

Does Axel Capital Management, LLC own Abbvie Inc (ABBV)? Not currently — the last reported position was 59.0K shares worth $10M in Q1 2022; the fund’s latest 13F (Q4 2022) no longer reports it.

Position Value
$10M
Q1 2022
Shares
59.0K
% of Portfolio
+12.13%
Quarters Held
5
position exited

Position History ABBV

Reported value by quarter
Q2 ’20: $255,000Q2 ’20Q3 ’20: $228,000Q3 ’20Q4 ’20: $278,000Q4 ’20Q4 ’21: $2MQ4 ’21Q1 ’22: $10MQ1 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202259.0K$10M+12.13%
Q4 202117.0K$2M+2.26%
Q4 20202.6K$278,000+0.09%
Q3 20202.6K$228,000+0.10%
Q2 20202.6K$255,000+0.19%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Axel Capital Management, LLC’s full portfolio or all institutional holders of ABBV.